Literature DB >> 1931623

Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?

N J Bundred1, R R West, J O Dowd, R E Mansel, L E Hughes.   

Abstract

A consecutive series of 644 women who presented with breast nodularity between 1976 and 1982 have been followed up to determine their rate of subsequent breast cancer. Fifteen women have developed breast cancer, 14 of these were among 352 women with an aspirated cyst (relative risk 4.4). Women with multiple cysts had the highest risk and women with breast nodularity had no excess risk. Review of histology specimens from those women who had undergone biopsy showed an excess of florid epithelial hyperplasia in women who subsequently developed breast cancer and women with multiple aspirated cysts were more likely to have florid epithelial hyperplasia. Multiple cysts are clinical markers of histological breast proliferation and women who have had multiple breast cysts aspirated have an increased risk of breast cancer and should be advised to practice regular self examination.

Entities:  

Mesh:

Year:  1991        PMID: 1931623      PMCID: PMC1977475          DOI: 10.1038/bjc.1991.433

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

Review 1.  CYSTIC DISEASE OF THE BREAST: RELATIONSHIP TO CARCINOMA.

Authors:  H H DAVIS; M SIMONS; J B DAVIS
Journal:  Cancer       Date:  1964-08       Impact factor: 6.860

2.  Importance of a high tracing-rate in long-term medical follow-up studies.

Authors:  A C Sims
Journal:  Lancet       Date:  1973-08-25       Impact factor: 79.321

3.  Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders.

Authors:  L E Hughes; R E Mansel; D J Webster
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

4.  Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein.

Authors:  D E Haagensen; G Mazoujian; W G Dilley; C E Pedersen; S J Kister; S A Wells
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

5.  Risk of breast cancer in women with history of benign disease of the breast.

Authors:  M M Roberts; V Jones; R A Elton; R W Fortt; S Williams; I H Gravelle
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

6.  Classification of human breast cysts according to electrolyte and androgen conjugate composition.

Authors:  W R Miller; J M Dixon; W N Scott; A P Forrest
Journal:  Clin Oncol       Date:  1983-09

7.  Relation between component parts of fibrocystic disease complex and breast cancer.

Authors:  D L Page; R Vander Zwaag; L W Rogers; L T Williams; W E Walker; W H Hartmann
Journal:  J Natl Cancer Inst       Date:  1978-10       Impact factor: 13.506

8.  The presentation and progress of macroscopic breast cysts.

Authors:  B M Jones; J W Bradbeer
Journal:  Br J Surg       Date:  1980-09       Impact factor: 6.939

9.  Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.

Authors:  M Dhont; L Delbeke; J van Eyck; L Voorhoof
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

10.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

  10 in total
  9 in total

1.  Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.

Authors:  M Malatesta; F Mannello; M Sebastiani; G Gazzanelli
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 2.  The enigmatic nature of apocrine breast lesions.

Authors:  P Zagorianakou; N Zagorianakou; D Stefanou; G Makrydimas; N J Agnantis
Journal:  Virchows Arch       Date:  2006-03-29       Impact factor: 4.064

3.  Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease.

Authors:  G H Borchert; H Yu; G Tomlinson; M Giai; R Roagna; R Ponzone; L Sgro; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Expression and prognostic significance of apolipoprotein D in breast cancer.

Authors:  I Díez-Itza; F Vizoso; A M Merino; L M Sánchez; J Tolivia; J Fernández; A Ruibal; C López-Otín
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

Review 5.  Non-operative breast pathology: apocrine lesions.

Authors:  C A Wells; G A El-Ayat
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

6.  Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.

Authors:  F Mannello; G Bocchiotti; G Bianchi; F Marcheggiani; G Gazzanelli
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.

Authors:  R Torrisi; S Zanardi; F Pensa; G Valenti; V De Franchis; G Nicolo; A Barreca; F Minuto; F Boccardo
Journal:  Breast Cancer Res Treat       Date:  1995-03       Impact factor: 4.872

8.  Angiotensin-converting enzyme and enkephalinase in human breast cyst fluid.

Authors:  K L Frame; K Patton; M J Reed; M W Ghilchik; D C Parish
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

9.  Impact of preventive therapy on the risk of breast cancer among women with benign breast disease.

Authors:  Jack Cuzick; Ivana Sestak; Mangesh A Thorat
Journal:  Breast       Date:  2015-11       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.